Whole Recombinant Saccharomyces cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients With Solid Tumors Bearing Ras Mutations: Results From a Phase 1 Trial.

doi:10.1097/CJI.0000000000000219

Article

Whole Recombinant Saccharomyces cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients With Solid Tumors Bearing Ras Mutations: Results From a Phase 1 Trial.

Journal of immunotherapy (Hagerstown, Md. : 1997) - 1 Apr 2018

Cohn Allen, Morse Michael A, O'Neil Bert, Whiting Samuel, Coeshott Claire, Ferraro John, Bellgrau Donald, Apelian David, Rodell Timothy C

Abstract excerpt

We are developing whole, heat-killed, recombinant Saccharomyces cerevisiae yeast, engineered to encode target proteins, which stimulate immune responses against malignant cells expressing those targets. This phase 1 trial, enrolling patients with advanced colorectal or pancreas cancer, was designed to evaluate safety, immunogenicity, response, and overall survival of ascending doses of the GI-4000 series of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Whole Recombinant Saccharomyces cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients With Solid Tumors Bearing Ras Mutations: Results From a Phase 1 Trial.

Abstract excerpt

Topics

Related research